Q32 Bio Inc. (QTTB) director awarded 10,826 options at $12.64 strike
Rhea-AI Filing Summary
Q32 Bio Inc. director Mary Thistle received a corrected grant of 10,826 stock options on June 12, 2026. The options have an exercise price of $12.64 per share, expire on June 11, 2036, and vest in full on the earlier of June 12, 2027 or the next annual stockholders’ meeting, subject to continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Thistle Mary
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1, F2 | 10,826 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 10,826 shares (Direct)
Footnotes (2)
- F1. This Form 4 amendment is being filed solely to amend the Form 4 filed on June 16, 2026 to correct the number of options awarded to the Reporting Person on June 12, 2026.
- F2. The shares underlying this option shall vest and become exercisable in full upon the earlier of (i) June 12, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service on such vesting date.
Key Figures
Options granted: 10,826 options
Exercise price: $12.64 per share
Options after grant: 10,826 options
+2 more
5 metrics
Options granted
10,826 options
Stock Option (Right to Buy) granted to director Mary Thistle on June 12, 2026
Exercise price
$12.64 per share
Conversion or exercise price for the stock options
Options after grant
10,826 options
Total options held from this grant following the transaction
Option expiration date
June 11, 2036
Expiration date of the stock option award
Latest vesting date
June 12, 2027
Options vest earlier of June 12, 2027 or next annual meeting, subject to continued service
Key Terms
Stock Option (Right to Buy), exercise price, vest and become exercisable, annual meeting of stockholders
4 terms
Stock Option (Right to Buy) financial
"security_title is listed as "Stock Option (Right to Buy)""
exercise price financial
"The option has a conversion or exercise price of 12.6400"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest and become exercisable financial
"The shares underlying this option shall vest and become exercisable in full"
annual meeting of stockholders regulatory
"earlier of (i) June 12, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transaction did QTTB director Mary Thistle report in this Form 4/A?
Mary Thistle reported a grant of 10,826 stock options in Q32 Bio Inc. These options were awarded on June 12, 2026 as director compensation and give her the right to purchase Q32 Bio common stock at a fixed exercise price in the future.
What is the exercise price of the stock options granted to QTTB director Mary Thistle?
The stock options granted to Mary Thistle carry an exercise price of $12.64 per share. This means she may buy Q32 Bio common stock at $12.64 per share once the options vest and before they expire, regardless of the market price then.
When do Mary Thistle’s QTTB stock options vest and become exercisable?
The options will vest and become exercisable in full on the earlier of June 12, 2027 or Q32 Bio’s next annual meeting of stockholders. Vesting is subject to her continued service as of that vesting date, as described in the footnote.
What change does this Form 4/A amendment for QTTB disclose?
The amendment states it was filed to correct the number of options awarded to Mary Thistle on June 12, 2026. After correction, she is reported as holding 10,826 stock options from this grant, replacing the previously reported amount.
How many QTTB stock options does Mary Thistle hold from this reported grant after the transaction?
Following the reported grant, Mary Thistle holds 10,826 stock options from this award. The filing shows this as her total position in this specific option grant, all held directly, subject to vesting and the stated expiration date in 2036.